Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,516 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Meme coins can surprise with sudden moves, and Pepe is no exception. This article unpacks the drivers behind a sharp ...
Ripple ETFs post a tepid week of inflows while XRP clings close to $1.40, as traders wrestle with whether the initial...
A veteran's take on holding (onon) 2025 earnings: what to watch, where margins could move, and how to plan for the Q4...
Tesla is signaling a bold move beyond traditional EVs. This article examines tesla stock's bold strategic shift, what...
UK gilts lead a global selloff as oil spikes after Iran tensions, widening the gap with peers and fueling bets on hig...
A new breed of data firms is staking its future on owning compute. This land data startup is buying GPUs and mapping ...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
Cherry Hill Mortgage Investment trades with a striking 15.4% yield, yet a history of dividend cuts and margin pressur...
Goldman Sachs has quietly built a $154 million stake in spot XRP ETFs, making it the largest disclosed holder as XRP ...
The World Gold Council unveiled a blockchain-backed trust layer to link physical gold vaults with digital rails, sign...